Obesity and risk for chronic renal failure

被引:484
作者
Ejerblad, Elisabeth
Fored, C. Michael
Lindblad, Per
Fryzek, Jon
McLaughlin, Joseph K.
Nyren, Olof
机构
[1] Univ Uppsala Hosp, Dept Hematol, SE-75185 Uppsala, Sweden
[2] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[3] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden
[4] Karolinska Univ Hosp, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[5] Karolinska Univ Hosp, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden
[6] Sundsvall Hosp, Dept Urol, Sundsvall, Sweden
[7] Int Epidemiol Inst, Rockville, MD USA
[8] Vanderbilt Univ, Ctr Med, Dept Med, Nashville, TN 37232 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 06期
关键词
D O I
10.1681/ASN.2005060638
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Few large-scale epidentiologic studies have quantified the possible link between obesity and chronic renal failure (CRF). This study analyzed anthropometric data from a nationwide, population-based, case-control study of incident, moderately severe CRF. Eligible as cases were all native Swedes who were aged 18 to 74 yr and had CRF and whose serum creatinine for the first time and permanently exceeded 3.4 mg/dl (men) or 2.8 mg/dl (women) during the study period. A total of 926 case patients and 998 control subjects, randomly drawn from the study base, were enrolled. Face-to-face interviews, supplemented with self-administered questionnaires, provided information about anthropometric measures and other lifestyle factors. Logistic regression models with adjustments for several co-factors estimated the relative risk for CRF in relation to body mass index (BMI). Overweight (BMI >= 25 kg/m(2)) at age 20 was associated with a significant three-fold excess risk for CRF, relative to BMI < 25. Obesity (BMI >= 30) among men and morbid obesity (BMI >= 35) among women anytime during lifetime was linked to three- to four-fold increases in risk. The strongest association was with diabetic nephropathy, but two- to three-fold risk elevations were observed for all major subtypes of CRF. Analyses that were confined to strata without hypertension or diabetes revealed a three-fold increased risk among patients who were overweight at age 20, whereas the two-fold observed risk elevation among those who had a highest lifetime BMI of > 35 was statistically nonsignificant. Obesity seems to be an important-and potentially preventable-risk factor for CRF. Although hypertension and type 2 diabetes are important mediators, additional pathways also may exist.
引用
收藏
页码:1695 / 1702
页数:8
相关论文
共 37 条
[1]   Prevalence and socio-economic aspects of chronic kidney disease [J].
Bommer, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :8-12
[2]   Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis [J].
Bonnet, F ;
Deprele, C ;
Sassolas, A ;
Moulin, P ;
Alamartine, E ;
Berthezène, F ;
Berthoux, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :720-727
[3]   Risk of end-stage renal disease in diabetes mellitus - A prospective cohort study of men screened for MRFIT [J].
Brancati, FL ;
Whelton, PK ;
Randall, BL ;
Neaton, JD ;
Stamler, J ;
Klag, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (23) :2069-2074
[4]   Microalbuminuria in nondiabetic adults - Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study [J].
Cirillo, M ;
Senigalliesi, L ;
Laurenzi, M ;
Alfieri, R ;
Stamler, J ;
Stamler, R ;
Panarelli, W ;
De Santo, NG .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (17) :1933-1939
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Obesity and target organ damage: the kidney [J].
de Jong, PE ;
Verhave, JC ;
Pinto-Sietsma, SJ ;
Hillege, HL .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 4) :S21-S24
[7]   Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia [J].
Esmatjes, E ;
Castell, C ;
Gonzalez, T ;
Tresserras, R ;
Lloveras, G ;
Bergua, M ;
Costa, B ;
Gimenez, G ;
Goday, A ;
Gutierrez, A ;
Micalo, T ;
Porta, M ;
delPozo, C ;
Ricart, W ;
Salinas, I ;
Sarda, P ;
Sarto, A ;
Simo, R ;
Sole, M ;
Utges, P ;
Vendrell, J ;
Vinzia, C ;
Agusti, M ;
Alonso, J ;
Andres, M ;
Anglada, J ;
Arasa, M ;
Arce, MA ;
Arroyo, J ;
Asencio, AJ ;
Bartolome, D ;
Bartolome, R ;
Benaiges, D ;
Bernat, E ;
Blai, C ;
Bragues, J ;
Camps, C ;
Cano, F ;
Casajoana, J ;
Casals, J ;
Castell, E ;
Castella, C ;
Costa, X ;
Cubells, MJ ;
Delfo, T ;
Deniel, J ;
Domaso, A ;
Espinas, J ;
Famades, A ;
FernandezReal, JL .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1996, 32 (03) :157-163
[8]  
FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
[9]   Acetaminophen, aspirin, and chronic renal failure. [J].
Fored, CM ;
Ejerblad, E ;
Lindblad, P ;
Fryzek, JP ;
Dickman, PW ;
Signorello, LB ;
Lipworth, L ;
Elinder, C ;
Blot, WJ ;
McLaughlin, JK ;
Zack, MM ;
Nyren, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1801-1808
[10]   Predictors of new-onset kidney disease in a community-based population [J].
Fox, CS ;
Larson, MG ;
Leip, EP ;
Culleton, B ;
Wilson, PWF ;
Levy, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (07) :844-850